Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party (Q46124555)
Jump to navigation
Jump to search
scientific article published on 11 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party |
scientific article published on 11 February 2009 |
Statements
1 reference
Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party (English)
1 reference
1 reference
1 reference
GIMEMA CML Working Party
1 reference
Gianantonio Rosti
1 reference
Fausto Castagnetti
1 reference
Giuliana Alimena
1 reference
Giovanni Martinelli
1 reference
Michele Baccarani
1 reference
Massimo Breccia
1 reference
Simona Luatti
1 reference
Ilaria Iacobucci
1 reference
Giovanna Rege Cambrin
1 reference
Marilina Amabile
1 reference
Fabrizio Pane
1 reference
Piero Galieni
1 reference
Franco Iuliano
1 reference
11 February 2009
1 reference
1 reference
113
1 reference
15
1 reference
3428-3434
1 reference
Identifiers
1 reference